Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 1096 AL 1110

Associations between selected genetic variants and lipid profile variability in response to statins in Alzheimer's disease: a prospective observational study

Oliveira FF, Almeida SS, Chen ES, Bertolucci PHF, Smith MC.

Sao Paulo Med J. 2025 Aug 15;143(4):e2024160. doi: 10.1590/1516-3180.2024.0160.27112024. eCollection 2025.

A systematic review and meta-analysis on the characteristics of transcranial magnetic stimulation treatment protocols for patients with Alzheimer's disease

Fuseya K, Mimura Y, Nakajima S, Mimura M, Kasanuki K, Noda Y.

J Alzheimers Dis. 2025 May;105(1):28-43. doi: 10.1177/13872877251325887. Epub 2025 Mar 20.

Telomere dynamics are influenced by sleep, sleep variability and circadian rhythms in older adults with or without alzheimer's risk

Lehodey A, Montagne B, Rehel S, Kaliman P, Chocat A, Mezenge F, Landeau B, de la Sayette V, Chételat G, Rauchs G, Poisnel G; Medit-Ageing Research Group.

Alzheimers Res Ther. 2025 Dec 5;18(1):10. doi: 10.1186/s13195-025-01923-3.

The causal association between circulating metabolites and Alzheimer's disease: a systematic review and meta-analysis of Mendelian randomization studies

Wu Y, Chen F, Zhang T, Miao M, Zhang M, Zhang J, Chang E.

Metabolomics. 2025 Apr 21;21(3):53. doi: 10.1007/s11306-025-02242-2.

Interplay between depressive symptoms and Alzheimer's disease dementia: unraveling the potential roles of ADAM10 and Negr1

Barroso de Sousa D, Zucato MCR, Ribeiro HM, Alexandre-Silva V, Cominetti MR.

Neuroscience. 2025 Oct 1;584:60-64. doi: 10.1016/j.neuroscience.2025.08.012. Epub 2025 Aug 12.

Role of Leptin and Adiponectin in the Management of Alzheimer's Disease: A Systematic Review

Adil M, Ghulammohiuddin F, Khalid N.

Eur J Neurosci. 2025 Nov;62(9):e70326. doi: 10.1111/ejn.70326.

Acoustic Stimulation to Improve Slow-Wave Sleep in Alzheimer's Disease: A Multiple Night At-Home Intervention

Van den Bulcke L, Davidoff H, Heremans E, Potts Y, Vansteelandt K, De Vos M, Christiaens D, Emsell L, Jacobson LH, Hoyer D, Buyse B, Vandenbulcke M, Testelmans D, Van Den Bossche M.

Am J Geriatr Psychiatry. 2025 Jan;33(1):73-84. doi: 10.1016/j.jagp.2024.07.002. Epub 2024 Jul 8.

Multi-ancestry meta-analysis identifies genetic modifiers of age-at-onset of Alzheimer's disease at known and novel loci

Blue EE, Broome J, Xue D, Kingston H, Chapman NH, Gogarten S; Alzheimer's Disease Genetics Consortium (ADGC); Naj AC, Wijsman EM.

Alzheimers Dement. 2025 Sep;21(9):e70489. doi: 10.1002/alz.70489.

Efficacy of probiotic supplementation in influencing cognitive function in Alzheimer's disease: A systematic review and meta-analysis

Liu W, Guo J, Dong Y, Li J, Wang Y.

J Food Sci. 2025 Jul;90(7):e70037. doi: 10.1111/1750-3841.70037.

Knowledge and attitude of pharmacists about Alzheimer's disease: A systematic review

Forgerini M, Cabral DA, Dos Santos MAB, Mastroianni PC, Lima TM.

Curr Pharm Teach Learn. 2025 Aug;17(8):102366. doi: 10.1016/j.cptl.2025.102366. Epub 2025 May 2.

Efficacy of AD04, an aluminum-based vaccine adjuvant, in patients with early Alzheimer's disease: Post hoc analysis of AFF006 (NCT01117818), a proof-of-concept, phase 2 randomized controlled trial

Haaland B, Dickson SP, Santana AF, Tanzi RE, Dubois B, Peters O, Grimmer T, Christensen J, Mallinckrodt C, Schneeberger A, Hendrix SB.

J Alzheimers Dis. 2025 Nov;108(1):234-242. doi: 10.1177/13872877251375985. Epub 2025 Sep 15.

Synthetic control methods for n-of-1 and parallel-group trials in Alzheimer's disease: A proof-of-concept study using the I-CONECT

Wu CY, Chen L, Dickson JR, Zhang B, Arnold SE, Dodge HH.

Alzheimers Dement. 2025 Jul;21(7):e70460. doi: 10.1002/alz.70460.

Cognitive behavioural treatment for mild Alzheimer's patients and their caregivers (CBTAC): results of a randomised controlled trial

Forstmeier S, Maercker A, Bohli L, Savaskan E, Roth T.

Aging Ment Health. 2025 Feb;29(2):359-368. doi: 10.1080/13607863.2024.2393748. Epub 2024 Aug 20.

Safety, tolerability, pharmacokinetic and pharmacodynamic effects of the muscarinic M(1) positive allosteric modulator VU0467319 for Alzheimer's disease: a single ascending-dose study in healthy participants

Conley AC, Key AP, Blackford JU, Russell JK, Albert KM, Gong X, Bubser M, Rook JM, Conn PJ, Lindsley CW, Jones CK, Newhouse PA.

Alzheimers Res Ther. 2025 Jul 1;17(1):144. doi: 10.1186/s13195-025-01798-4.

Understanding domains of awareness in Alzheimer's disease: a longitudinal study

Lacerda IB, Baptista MAT, Nogueira MML, Belfort T, de Oliveira Silva F, Dourado MCN.

Aging Ment Health. 2025 Aug;29(8):1387-1397. doi: 10.1080/13607863.2025.2486430. Epub 2025 Apr 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias